8-K Filing

Company

Cocrystal Pharma, Inc.

Filed

June 28, 2024

Period of Report

June 25, 2024

Accession Number

0001493152-24-025598

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →